Tamás Treuer

2.2k total citations
88 papers, 1.4k citations indexed

About

Tamás Treuer is a scholar working on Psychiatry and Mental health, Clinical Psychology and Rheumatology. According to data from OpenAlex, Tamás Treuer has authored 88 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Psychiatry and Mental health, 15 papers in Clinical Psychology and 10 papers in Rheumatology. Recurrent topics in Tamás Treuer's work include Schizophrenia research and treatment (43 papers), Bipolar Disorder and Treatment (27 papers) and Attention Deficit Hyperactivity Disorder (14 papers). Tamás Treuer is often cited by papers focused on Schizophrenia research and treatment (43 papers), Bipolar Disorder and Treatment (27 papers) and Attention Deficit Hyperactivity Disorder (14 papers). Tamás Treuer collaborates with scholars based in United States, Hungary and United Kingdom. Tamás Treuer's co-authors include William Montgomery, Mauricio Tohen, Diego Novick, Josep María Haro, Ján Pečeňák, Kaname Ueda, Yulia Dyachkova, Martín Dossenbach, Jamie Karagianis and Susanne A. Kraemer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Tamás Treuer

83 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tamás Treuer 1.1k 306 140 137 128 88 1.4k
Shang‐Ying Tsai 1.9k 1.7× 700 2.3× 70 0.5× 147 1.1× 92 0.7× 133 2.8k
Tilman Wetterling 864 0.8× 508 1.7× 46 0.3× 141 1.0× 249 1.9× 99 2.0k
Raveen Hanwella 609 0.6× 425 1.4× 96 0.7× 156 1.1× 183 1.4× 75 1.4k
Eugene Cassidy 479 0.4× 320 1.0× 70 0.5× 53 0.4× 109 0.9× 54 1.3k
Michael D. Stensland 786 0.7× 160 0.5× 79 0.6× 196 1.4× 241 1.9× 30 1.1k
Varuni De Silva 527 0.5× 355 1.2× 78 0.6× 160 1.2× 187 1.5× 58 1.3k
Arianna Goracci 338 0.3× 356 1.2× 114 0.8× 106 0.8× 111 0.9× 56 1.0k
Jamie Kane 887 0.8× 284 0.9× 152 1.1× 144 1.1× 66 0.5× 13 1.2k
Kai G. Kahl 342 0.3× 342 1.1× 50 0.4× 80 0.6× 140 1.1× 60 1.2k
Roberto Quartesan 482 0.4× 338 1.1× 112 0.8× 112 0.8× 79 0.6× 57 1.2k

Countries citing papers authored by Tamás Treuer

Since Specialization
Citations

This map shows the geographic impact of Tamás Treuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamás Treuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamás Treuer more than expected).

Fields of papers citing papers by Tamás Treuer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamás Treuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamás Treuer. The network helps show where Tamás Treuer may publish in the future.

Co-authorship network of co-authors of Tamás Treuer

This figure shows the co-authorship network connecting the top 25 collaborators of Tamás Treuer. A scholar is included among the top collaborators of Tamás Treuer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamás Treuer. Tamás Treuer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Littlejohn, Geoffrey, Tamás Treuer, Kathryn Gibson, et al.. (2023). Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset. Clinical and Experimental Rheumatology. 42(9). 1763–1772. 2 indexed citations
2.
Littlejohn, Geoffrey, Tamás Treuer, Kathryn Gibson, et al.. (2023). Comparative Effectiveness of First‐Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set. ACR Open Rheumatology. 5(7). 345–353. 2 indexed citations
3.
Alten, Rieke, Gerd R Burmester, Marco Matucci‐Cerinic, et al.. (2023). P131 Time to Discontinuation and Effectiveness with Baricitinib in Rheumatoid Arthritis: 12-Month European Data from a Multinational, Prospective, Observational Study. Lara D. Veeken. 62(Supplement_2). 1 indexed citations
4.
Morel, Jacques, Ennio Lubrano, William Tillett, et al.. (2023). AB1115 STUDY DESIGN AND FULL BASELINE SAMPLE CHARACTERISTICS OF PATIENTS FROM THE 24-MONTH MULTINATIONAL PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT (PRO-SPIRIT). Annals of the Rheumatic Diseases. 82. 1786–1787. 1 indexed citations
5.
Nakanishi, Miharu, Ataru Igarashi, Kaname Ueda, et al.. (2020). Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer’s Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study. Journal of Alzheimer s Disease. 74(1). 127–138. 19 indexed citations
6.
Novick, Diego, William Montgomery, Tamás Treuer, et al.. (2017). Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder. Patient Preference and Adherence. Volume 11. 1019–1025. 10 indexed citations
7.
Novick, Diego, William Montgomery, Tamás Treuer, María Victoria Moneta, & Josep María Haro. (2016). Sex differences in the course of schizophrenia across diverse regions of the world. Neuropsychiatric Disease and Treatment. Volume 12. 2927–2939. 30 indexed citations
8.
Lee, Soyoung Irene, Soyoung Irene Lee, Dong‐Ho Song, et al.. (2014). Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder. Asia-Pacific Psychiatry. 6(4). 386–396. 13 indexed citations
9.
10.
11.
Treuer, Tamás, Chia-Yih Liu, Gerardo A. Salazar, et al.. (2013). Use of antidepressants in the treatment of depression in Asia: Guidelines, clinical evidence, and experience revisited. Asia-Pacific Psychiatry. 5(4). 219–230. 10 indexed citations
12.
Treuer, Tamás, Susan Shur‐Fen Gau, Luis Méndez, et al.. (2013). A Systematic Review of Combination Therapy with Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder, Including Patient Characteristics, Treatment Strategies, Effectiveness, and Tolerability. Journal of Child and Adolescent Psychopharmacology. 23(3). 179–193. 39 indexed citations
13.
Montgomery, William, et al.. (2012). Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. SHILAP Revista de lepidopterología.
14.
15.
Wang, Gang, et al.. (2011). Factors associated with weight gain during six-month olanzapine therapy. Chin J Psychiatry. 44(3). 145–150. 4 indexed citations
16.
Şaylan, Mete, Alp Üçok, Şükrü Uğuz, Tamás Treuer, & Aytekin Sır. (2009). Analysis of social class by LCA in patients with schizophrenia: change in psychopathology after 12-month of treatment -. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(1). 29–38. 3 indexed citations
17.
Martényi, Ferenc, Tamás Treuer, Susan Shur‐Fen Gau, et al.. (2009). Attention-Deficit/Hyperactivity Disorder Diagnosis, Co-Morbidities, Treatment Patterns, and Quality of Life in a Pediatric Population in Central and Eastern Europe and Asia. Journal of Child and Adolescent Psychopharmacology. 19(4). 363–376. 22 indexed citations
18.
Szendi, István, et al.. (2007). [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].. PubMed. 9(3). 115–24.
19.
Lis, Joanna, et al.. (2004). [Prospective observational study of outpatients with schizophrenia in Poland: preliminary 6 month efficacy and tolerability results].. PubMed. 38(3). 469–84. 1 indexed citations
20.
Németh, Artúr, et al.. (1997). Epidemiology of OCD in Hungary. European Neuropsychopharmacology. 1002(7). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shang‐Ying Tsai Breakdown of academic impact, for papers by Tilman Wetterling Breakdown of academic impact, for papers by Raveen Hanwella Breakdown of academic impact, for papers by Eugene Cassidy Breakdown of academic impact, for papers by Michael D. Stensland Breakdown of academic impact, for papers by Varuni De Silva Breakdown of academic impact, for papers by Arianna Goracci Breakdown of academic impact, for papers by Jamie Kane Breakdown of academic impact, for papers by Kai G. Kahl Breakdown of academic impact, for papers by Roberto Quartesan
Rankless by CCL
2026